An observational study in Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, sponsored by Thomas Jefferson University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-22.
Sponsored by Thomas Jefferson University · Observational
This study identifies patient-important outcome measures and develops a survey that assesses the impact of nutritional interventions among cancer patients. Currently, data on the impact of medically tailored meals on outcomes that are meaningful to patients, providers, and payers are limited. For this reason, access to medically tailored meals as a covered benefit for cancer patients is limited. Thus, there is a need to explore the efficacy of nutritional interventions among this population. This study identifies outcome measures for nutritional interventions that are meaningful to patients and providers.
PRIMARY OBJECTIVES:
I. To identify patient-important outcomes related to receiving nutrition services by engaging patients with cancer and clinicians.
II. To conduct cognitive interviews to assess comprehension, acceptability, and appropriateness of patient-identified outcomes in aim 1.
III. To pilot test the use of the nutrition-related outcome measures identified in aim 1 among a sample of oncology patients.
OUTLINE:
Part I: Patients and clinicians attend semi-structured interviews over 20-30 minutes or cognitive interviews over 60 minutes in support of survey refinement.
Part II: Patients complete survey over 15 minutes.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
This study's enrollment of 46 is below the median of 204 across 1,683 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Thomas Jefferson University is the lead sponsor of 384 studies on the registry; 71 are open to participants now.
Of its 44 completed or terminated interventional studies of FDA-regulated products, 20 (45%) have results posted.
Counted across the registry records on this site, refreshed daily.
Population includes cancer patients at Sidney Kimmel Cancer Center (SKCC), clinicians and MANNA clients.
AIM 1 PATIENTS: English speaking
* Pending funding and staff abilities, efforts will be made to include other languages if possible
AIM 1 PATIENTS: 10 patients currently receiving cancer treatment for curative intent, screen positive for nutrition risk, and report food insecurity
* Nutrition risk = a score of >= 2 on the Malnutrition Screening Tool, weight loss of 5% over 1 months, or weight loss of > 10% over 6 months
AIM 2 PATIENTS: English speaking
AIM 2 PATIENTS: 3-5 patients currently receiving cancer treatment for curative intent, screen positive for nutrition risk, and report food insecurity
* Nutrition risk = a score of >= 2 on the Malnutrition Screening Tool, weight loss > 5% over 1 month, or weight loss of > 10% over 6 months
Exclusion Criteria:
Part I: Patients and clinicians attend semi-structured interviews over 20-30 minutes or cognitive interviews over 60 minutes in support of survey refinement. Part II: Patients complete survey over 15 minutes.
Other: Interview · Other: Survey Administration
Attends Interviews
Complete Survey
identify patient-important outcomes related to receiving nutrition services by engaging patients with cancer and clinicians
Reported as average time required to complete each assessment.
Time frame: At study completion; approximately 60 minutes
Usability
Reported as average time required to complete each assessment.
Time frame: At study completion; approximately 60 minutes
Feasibility
Reported as the number of participants who are able to complete the entire list of assessments to receive nutrition services.
Time frame: At study completion; approximately 60 minutes
This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Thomas Jefferson University